After the founding of New China, it was directly under the leadership of the Ministry of Health. Now it is an important member of China National Pharmaceutical Group Co., Ltd., a fortune 500 enterprise in the world. It is a comprehensive biopharmaceutical enterprise with a long history, complete products and large scale in China, integrating scientific research, production, sales and postgraduate training. There are 12 secondary subsidiaries, 76 subsidiaries below the secondary level, and employees 1255 1 person.
Biological development and scientific research strength in China.
China has a rich biological product line, covering six biological products: vaccines for human use, blood products, medical beauty, animal health care, antibody drugs and medical diagnosis. The annual output of human vaccines is 50 kinds, with an annual output of more than 700 million doses, ranking sixth in the world, providing more than 80% vaccines for the national immunization program.
China has a strong biotechnology innovation strength, with more than 10,000 people in R&D team and more than 10,000 people in quality management team, including academician of China Academy of Engineering, chief scientist of National "863" Vaccine Project, and member of National Pharmacopoeia Committee. There are five postdoctoral workstations, one doctoral degree awarding point 1 and five master degree awarding points, which have delivered a large number of high-end talents for the development of biopharmaceutical industry in China.
Refer to the above? China Biotechnology Co., Ltd.-Know us.